Nephrocare Health Services Ltd.

•

nephroplus.comBSE: 544647NSE: NEPHROPLUS

Market Cap₹ 7,012 Cr.

Current Price

High / Low₹ 770 / 446

Stock P/E0.0

Book Value₹ 96

Price to Book5.32

Dividend Yield0.00 %

ROCE5.6 %

ROE-1.1 %

Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 8.96x)

CONS

Company is loss-making at the operating / net level
Recent results are weak - TTM profit is down 37.2% versus prior year
Company has a low return on equity of 2.4% over last 3 years
Company has a low return on capital employed of 6.0%
Interest coverage is weak at 0.9x - earnings barely cover interest

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	APOLLOHOSP	8670.00	59.66	124661.30	0.23	610.40	38.41	7043.50	20.56	21.73	15.70
2.	MANIPALHOS	729.75	107.57	95989.65	0.00	2434.30	—	30906.30	—	13.93	23.83
3.	MAXHEALTH	985.00	65.80	95867.73	0.20	322.96	4.87	2366.17	16.70	14.97	25.29
4.	FORTIS	910.00	65.56	68701.19	0.11	272.80	2.26	2545.03	17.46	14.07	21.28
5.	ASTERDM	785.80	214.94	68496.02	0.00	29.28	-68.70	1310.68	21.60	11.46	19.53
6.	MEDANTA	1468.85	71.01	39493.23	0.03	157.25	-1.09	1304.05	26.50	19.38	21.99
7.	NH	1859.10	46.55	37992.72	0.24	207.27	5.37	2683.63	78.05	16.20	17.43
8.	KIMS	764.15	157.10	32094.80	0.00	37.40	-56.00	1179.50	35.33	11.51	19.03
9.	LALPATHLAB	1874.90	58.07	31469.98	1.09	1705.00	1172.39	7977.00	1090.95	29.56	31.03
10.	AGARWALEYE	514.15	109.86	16299.90	0.00	55.02	44.56	614.02	25.97	16.14	27.75
11.	VIJAYA	1496.35	82.20	15412.06	0.13	53.10	37.61	230.98	22.83	30.28	42.66
12.	NEPHROPLUS	697.35	91.26	7012.48	0.00	31.97	28.57	281.75	28.54	16.18	21.41

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Dec 2024	Mar 2025	Jun 2025	Dec 2025	Mar 2026	Jun 2026
	138	145	149	161	164	170
	116	123	145	138	142	160
Operating Profit	22	22	4	23	22	11
OPM %	16.25%	15.00%	2.64%	14.23%	13.43%	6.20%
	4	3	3	3	6	6
Interest	3	4	3	4	1	0
Depreciation	12	13	12	13	16	13
Profit before Tax	11	7	7	9	11	17
Tax %	24.84%	23.45%	27.31%	5.69%	1.00%	24.74%
Net Profit	8	6	5	8	11	13
	1.00	0.70	0.60	0.90	1.09	1.25

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	386	436	544	630	644
	348	384	449	542	585
Operating Profit	38	52	95	88	59
OPM %	9.83%	11.91%	17.45%	14.00%	9.22%
	5	8	16	15	19
Interest	15	17	14	50	9
Depreciation	41	43	51	58	55
Profit before Tax	-13	0	45	-4	44
Tax %	-20.08%	-1688.94%	24.52%	-113.85%	15.24%
Net Profit	-15	4	34	-8	37
EPS	-29.86	22.20	193.97	-0.80	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: 18%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: 2%
Last Year:: -1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	2	2	2	20
	383	393	524	933
	204	165	115	10
Trade Payables	14	41	61	85
	26	43	37	60
Total Liabilities	630	644	739	1,107
	169	219	234	245
Capital Work in Progress	0	1	4	4
	148	149	212	335
	22	19	18	18
	0	138	194	218
Cash & Bank	3	2	33	225
	287	117	43	63
Total Assets	630	644	739	1,107

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	7	57	80	133
Cash from Investing	-75	-23	-104	-299
Cash from Financing	63	-36	26	256
	-0	-1	2	90

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE
EPS (₹)	-88.89	22.20	193.97	-0.80
Book Value (₹)	2213.38	2255.24	2978.93	94.97
Dividend per Share (₹)	0.00	0.00	0.00	0.00
Cash EPS (₹)	29.24	53.30	96.42	4.94
PROFITABILITY
Operating Margin %	11.15%	11.91%	17.45%	14.00%
Net Margin %	-4.01%	0.89%	6.30%	-1.28%
ROE %	-4.02%	1.00%	7.44%	-1.09%
ROCE %	0.36%	2.90%	9.56%	5.61%
	-2.46%	0.61%	4.95%	-0.87%
EFFICIENCY
Debtor Days	122	112	111	119
Inventory Days	21	17	12	10
Payable Days	40	73	125	166
	103	56	-1	-36
FINANCIAL HEALTH
Debt to Equity (x)	0.51x	0.45x	0.23x	0.00x
Interest Coverage (x)	0.14x	1.01x	4.17x	0.92x
	1.80x	1.39x	2.14x	4.27x
GROWTH
Revenue Growth %	0.00%	12.98%	24.61%	15.85%
Operating Profit Growth %	0.00%	38.81%	84.91%	-6.26%
Net Profit Growth %	0.00%	125.10%	781.92%	-123.54%
	0.00%	124.97%	773.92%	-100.41%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x
P/B (x)	0.00x	0.00x	0.00x	5.32x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%
	0.00x	3.04x	0.86x	46.81x

Shareholding Pattern

Numbers in percentages

	Dec 2025	Mar 2026	Jun 2026
	63.85	63.85	63.85
	3.59	9.94	8.78
	7.75	8.64	9.05
Government	0.00	0.00	0.00
	23.88	17.56	18.32

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-03

Options to purchase securities

2026-09-03 - Nephrocare Health Services Limited has informed the Exchange about Grant of Employee Stock Options under the NephroPlus Employee Stock Option Scheme 2026.

2026-09-01

Agreements

2026-09-01 - Nephrocare Health Services Limited has informed the Exchange about Acquisition of 100% participatory interest in Dialysis Center Almaty LLP, Kazakhstan

2026-08-31

Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-31 - Nephrocare Health Services Limited has informed the Exchange about Tax demand pursuant to tax audit.

2026-08-19

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-19 - Nephrocare Health Services Limited has informed the Exchange about Transcript

2026-08-17

Agreements

2026-08-17 - Nephrocare Health Services Limited has informed the Exchange about Agreements

2026-08-13

Shareholders meeting

2026-08-13 - Nephrocare Health Services Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 12, 2026. Further, the company has informed the Exchange regarding voting results.

2026-08-13

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-13 - Nephrocare Health Services Limited has informed the Exchange about Schedule of meet

2026-08-13

Agreements

2026-08-13 - Nephrocare Health Services Limited has informed the Exchange about Agreements

2026-08-12

Disclosure of material issue

2026-08-12 - Nephrocare Health Services Limited has informed regarding Disclosure of material issue regarding Clarification to disclosure under Reg 30 dated May 26, 2026 regarding incorporation of Nephrocare Services Kazakhstan LLP.

News

Recent coverage and analyst commentary for NEPHROPLUS

Loading news…

🤖

AI Stock Analyst

Nephrocare Health Services Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

APOLLOHOSP

8670.00

59.66

124661.30

0.23

610.40

38.41

7043.50

20.56

21.73

15.70

MANIPALHOS

729.75

107.57

95989.65

0.00

2434.30

—

30906.30

—

13.93

23.83

MAXHEALTH

985.00

65.80

95867.73

0.20

322.96

4.87

2366.17

16.70

14.97

25.29

FORTIS

910.00

65.56

68701.19

0.11

272.80

2.26

2545.03

17.46

14.07

21.28

ASTERDM

785.80

214.94

68496.02

0.00

29.28

-68.70

1310.68

21.60

11.46

19.53

MEDANTA

1468.85

71.01

39493.23

0.03

157.25

-1.09

1304.05

26.50

19.38

21.99

1859.10

46.55

37992.72

0.24

207.27

5.37

2683.63

78.05

16.20

17.43

KIMS

764.15

157.10

32094.80

0.00

37.40

-56.00

1179.50

35.33

11.51

19.03

LALPATHLAB

1874.90

58.07

31469.98

1.09

1705.00

1172.39

7977.00

1090.95

29.56

31.03

AGARWALEYE

514.15

109.86

16299.90

0.00

55.02

44.56

614.02

25.97

16.14

27.75

VIJAYA

1496.35

82.20

15412.06

0.13

53.10

37.61

230.98

22.83

30.28

42.66

NEPHROPLUS

697.35

91.26

7012.48

0.00

31.97

28.57

281.75

28.54

16.18

21.41

Dec 2024

Mar 2025

Jun 2025

Dec 2025

Mar 2026

Jun 2026

138

145

149

161

164

170

116

123

145

138

142

160

Operating Profit

OPM %

16.25%

15.00%

2.64%

14.23%

13.43%

6.20%

Interest

Depreciation

Profit before Tax

Tax %

24.84%

23.45%

27.31%

5.69%

1.00%

24.74%

Net Profit

1.00

0.70

0.60

0.90

1.09

1.25

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

386

436

544

630

644

348

384

449

542

585

Operating Profit

OPM %

9.83%

11.91%

17.45%

14.00%

9.22%

Interest

Depreciation

Profit before Tax

-13

-4

Tax %

-20.08%

-1688.94%

24.52%

-113.85%

15.24%

Net Profit

-15

-8

EPS

-29.86

22.20

193.97

-0.80

—

Dividend Payout %

0.00%

—

Mar 2023

Mar 2024

Mar 2025

Mar 2026

383

393

524

933

204

165

115

Trade Payables

Total Liabilities

630

644

739

1,107

169

219

234

245

Capital Work in Progress

148

149

212

335

138

194

218

Cash & Bank

225

287

117

Total Assets

630

644

739

1,107

Mar 2023

Mar 2024

Mar 2025

Mar 2026

133

Cash from Investing

-75

-23

-104

-299

Cash from Financing

-36

256

-0

-1

Mar 2023

Mar 2024

Mar 2025

Mar 2026

PER SHARE

EPS (₹)

-88.89

22.20

193.97

-0.80

Book Value (₹)

2213.38

2255.24

2978.93

94.97

Dividend per Share (₹)

0.00

Cash EPS (₹)

29.24

53.30

96.42

4.94

PROFITABILITY

Operating Margin %

11.15%

11.91%

17.45%

14.00%

Net Margin %

-4.01%

0.89%

6.30%

-1.28%

ROE %

-4.02%

1.00%

7.44%

-1.09%

ROCE %

0.36%

2.90%

9.56%

5.61%

-2.46%

0.61%

4.95%

-0.87%

EFFICIENCY

Debtor Days

122

112

111

119

Inventory Days

Payable Days

125

166

103

-1

-36

FINANCIAL HEALTH

Debt to Equity (x)

0.51x

0.45x

0.23x

0.00x

Interest Coverage (x)

0.14x

1.01x

4.17x

0.92x

1.80x

1.39x

2.14x

4.27x

GROWTH

Revenue Growth %

0.00%

12.98%

24.61%

15.85%

Operating Profit Growth %

0.00%

38.81%

84.91%

-6.26%

Net Profit Growth %

0.00%

125.10%

781.92%

-123.54%

0.00%

124.97%

773.92%

-100.41%

VALUATION

P/E (x)

0.00x

P/B (x)

0.00x

5.32x

Dividend Yield %

0.00%

0.00x

3.04x

0.86x

46.81x

Dec 2025

Mar 2026

Jun 2026

63.85

3.59

9.94

8.78

7.75

8.64

9.05

Government

0.00

23.88

17.56

18.32

Nephrocare Health Services Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Nephrocare Health Services Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI